source: WorldVistAEHR/trunk/r/ONCOLOGY-ONC/ONCSSF3.m@ 1270

Last change on this file since 1270 was 613, checked in by George Lilly, 15 years ago

initial load of WorldVistAEHR
File size: 5.0 KB
Line 
1ONCSSF3 ;Hines OIFO/GWB - SITE-SPECIFIC FACTOR 3 (165.5,44.3) ;11/20/03
2 ;;2.11;ONCOLOGY;**40**;Mar 07, 1995
3 ;
4 ;SITE-SPECIFIC FACTOR 3 (165.5,44.3)
5SSF3IT ;INPUT TRANSFORM
6 ;
7 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
8 I PS="" K X W " No PRIMARY SITE defined for this primary" Q
9 S MO=$$HIST^ONCFUNC(D0)
10 ;
11 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-3")):$O(^ONCO(164.52,"C",PS_"-3",0)),1:1)
12 ;
13 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
14 I $$MELANOMA^ONCOU55(D0) D
15 .S MELIEN=$O(^ONCO(164.52,"B","CLINICAL STATUS OF LYMPH NODE ",0))
16 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
17 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
18 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
19 .I PS=67632 S SSFIEN=MELIEN Q
20 ;
21 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
22 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","IPI SCORE",0))
23 ;
24 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
25 ;Kaposi Sarcoma of All Sites
26 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
27 ;
28 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
29 ;Myeloproliferative Neoplasms
30 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
31 ;
32 ;Retinoblastoma
33 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0)) G SSF3I
34 ;
35 ;Breast
36 I $E(PS,3,4)=50,+X>0,+X<90 D G ITEX
37 .I X'?3N D K X Q
38 ..I X?1N W !!," For ",X," enter 00",X," "
39 ..I X?2N W !!," For ",X," enter 0",X," "
40 .W " ",X," nodes positive"
41 ;
42SSF3I I '$D(^ONCO(164.52,SSFIEN,1,"B",X)) K X Q
43 S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",X,0))
44 W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2)
45ITEX K PS,SSFIEN,SSF,MO,MELING Q
46 ;
47SSF3OT ;OUTPUT TRANSFORM
48 ;
49 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
50 Q:PS=""
51 S MO=$$HIST^ONCFUNC(D0)
52 ;
53 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-3")):$O(^ONCO(164.52,"C",PS_"-3",0)),1:1)
54 ;
55 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
56 I $$MELANOMA^ONCOU55(D0) D
57 .S MELIEN=$O(^ONCO(164.52,"B","CLINICAL STATUS OF LYMPH NODE ",0))
58 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
59 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
60 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
61 .I PS=67632 S SSFIEN=MELIEN Q
62 ;
63 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
64 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","IPI SCORE",0))
65 ;
66 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
67 ;Kaposi Sarcoma of All Sites
68 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
69 ;
70 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
71 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
72 ;
73 ;Retinoblastoma
74 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0)) G SSF3O
75 ;
76 ;Breast
77 I $E(PS,3,4)=50,+Y>0,+Y<90 S Y=Y_" nodes positive" G OTEX
78 ;
79SSF3O S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",Y,0)) I SSF="" G OTEX
80 S Y=$P($G(^ONCO(164.52,SSFIEN,1,SSF,0)),U,2)
81OTEX K PS,SSFIEN,SSF,MO Q
82 ;
83SSF3HP ;HELP
84 ;
85 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
86 Q:PS=""
87 S MO=$$HIST^ONCFUNC(D0)
88 ;
89 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-3")):$O(^ONCO(164.52,"C",PS_"-3",0)),1:1)
90 ;
91 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
92 I $$MELANOMA^ONCOU55(D0) D
93 .S MELIEN=$O(^ONCO(164.52,"B","CLINICAL STATUS OF LYMPH NODE ",0))
94 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
95 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
96 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
97 .I PS=67632 S SSFIEN=MELIEN Q
98 ;
99 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
100 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","IPI SCORE",0))
101 ;
102 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
103 ;Kaposi Sarcoma of All Sites
104 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
105 ;
106 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
107 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
108 ;
109 ;Retinoblastoma
110 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
111 ;
112 W !," SITE-SPECIFIC FACTOR 3 for " D
113 .I MO=97003 W "MYCOSIS FUNGOIDES of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
114 .I MO=97013 W "SEZARY SYNDROME of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
115 .I $E(MO,1,3)=951 W "RETINOBLASTOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
116 .I $$MELANOMA^ONCOU55(D0),($E(PS,3,4)=44)!($E(PS,3,4)=51)!($E(PS,3,4)=60)!(PS=67632)!($E(PS,3,4)=69) W "MALIGNANT MELANOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
117 .I $E(MO,1,4)=9140 W "KAPOSI SARCOMA of ALL SITES" Q
118 .I $$LYMPHOMA^ONCFUNC(D0) W "HODGKIN AND NON-HODGKIN LYMPHOMAS of ALL SITES" Q
119 .I (MO'<97310)&(MO'>99899) W $P(^ONCO(169.3,MO,0),U,1)," (",$P(^ONCO(169.3,MO,0),U,2),")" Q
120 .W $P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")"
121 W !," ",$P(^ONCO(164.52,SSFIEN,0),U,1)
122 ;S SSF=0 F S SSF=$O(^ONCO(164.52,SSFIEN,1,SSF)) Q:SSF'>0 D
123 ;.S TAB=6
124 ;.I ($P(^ONCO(164.52,SSFIEN,0),U,1)="NUMBER OF POSITIVE IPSILATERAL AXILLARY LYMPH NODES") S TAB=10
125 ;.W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,1),?TAB,$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2),!
126 K PS,SSFIEN,SSF,MO Q
Note: See TracBrowser for help on using the repository browser.